Research

Energy balance

The proportion achieving ≥ 20% TBWL was nearly two-fold higher in mild versus severe IMS (27% vs. 14%, p = 0.03).

Higher IMS severity is associated with lower chances of achieving significant weight loss with tirzepatide.

StrongSupportsmedium confidence
The proportion achieving ≥ 20% TBWL was nearly two-fold higher in mild versus severe IMS (27% vs. 14%, p = 0.03).
Regina Castaneda et al. · Diabetology · 2026

Why this rating

Based on a retrospective analysis of a large cohort (717 adults).

Source

Leveraging the Individualized Metabolic Surgery Score to Predict Weight Loss with Tirzepatide in Adults with Type 2 Diabetes and Obesity

Regina Castaneda et al. · Diabetology · 2026

DOI 10.3390/diabetology7010010

cohort · n=717
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →